Imneskibart will now enter late-stage trials after the drug offered durable tumour shrinkage in NSCLC, melanoma and other ...

In the MIROCALS trial, Gilbert Bensimon and colleagues1 showed that low-dose interleukin-2 (IL-2) added to riluzole did not significantly reduce mortality in an unadjusted analysis of patients with ...

We thank Yutaka Shimazu for his insightful comments. We agree that our positive findings1–4 highlight the urgent need for further work on biomarkers of neuronal damage and immune mechanisms in ...

Treatment with TNF-α inhibitors may be safer than IL-6 inhibitors in terms of cardiovascular outcomes when managing patients ...

Takeda is paying Innovent Biologics $1.2 billion upfront for rights to two cancer candidates. The deal, which includes (PDF) $10.2 billion in milestones, puts the biologics at the center of Takeda’s ...

Ortschaftsräte über Baufortschritt der neuen Kita in Ebnat informiert. Innovative Bauweise trifft auf ungewohnte Finanzierung ...

γ c family cytokines and the related cytokine thymic stromal lymphopoietin (TSLP) have distinct effects on the regulation of survival and proliferation of T cells. IL-2 and TSLP increase the ...

MANHATTAN, Ill. (WLS) -- Back-to-back losses are devastating a tight-knit community in the southwest suburbs. The support surrounding the families was evident in the hundreds of people that showed up ...

Chris is a writer and editor with over 10 years of experience covering games and has a bachelor's degree in History from the University of Central Lancashire. He's mainly focused on guides, but has ...